Pfizer collaborates with BioNTech to develop flu vaccines

16-08-2018

Pfizer collaborates with BioNTech to develop flu vaccines

Cat lane / iStockphoto.com

Pfizer has entered into a multi-year collaboration with immunotherapy company BioNTech to develop messenger ribonucleic acid-based (mRNA) vaccines for influenza.


Pfizer, BioNTech, mRNA, vaccines, influenza, flu, big pharma, collaboration, Kathrin Jansen, Ugur Sahin, immunotherapy

More on this story

Sanofi invests $200m in flu vaccine production
12-10-2017

LSIPR